Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer.
Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer. Glassberg, who served as director of the company until June 2006, joined Poniard after working at the University of California, San Francisco’s (UCSF, www.ucsf.edu) Comprehensive Cancer Center, where he served as associate director of clinical care and director of general oncology.
